ReviewZeitschrift fur Rheumatologie2019
Long-term trends in rheumatology care : Achievements and deficits in 25 years of the German national rheumatology database.
Review in Zeitschrift fur Rheumatologie, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
21 citing papers in PubMed, 1 synthesis or guideline pooled it.
- [Rheuma in motion-A positioning of exercise and movement therapy in chronic inflammatory rheumatic diseases].Zeitschrift fur Rheumatologie · 2025Pooled it
- [Survey of care situation for patients with systemic lupus erythematosus and systemic sclerosis with pulmonary involvement in Rhineland-Palatinate and Saarland].Zeitschrift fur Rheumatologie · 2026Article
- [Rheuma-VOR-Health economic evaluation of early rheumatological diagnosis : Summary of the G-BA report].Zeitschrift fur Rheumatologie · 2026Article
- Discordance between patient and physician reported global disease activity in PsA is associated with mental health-a cross-sectional analysis.Rheumatology international · 2025Article
- [Current patient care of systematic lupus erythematosus in Rhineland-Palatinate and Saarland].Zeitschrift fur Rheumatologie · 2024Article
- Trends in health care of patients with vasculitides, including giant cell arteritis, Takayasu arteritis, ANCA-associated vasculitis and Behçet's disease: cross-sectional data of the German National Database 2007-2021.Rheumatology international · 2024Article
- Rheuma-VOR study: optimising healthcare of rheumatic diseases by multiprofessional coordinating centres.Annals of the rheumatic diseases · 2024Article
- [Discipline-specific assessment of the report of the German Society of Internal Medicine e.V. (DGIM) on depiction of the treatment landscape in the field of internal medicine in Germany by the German Society for Rheumatology e.V. (DGRh)].Zeitschrift fur Rheumatologie · 2023Review
- [Position paper of the German Society of Rheumatology e.V. (DGRh) regarding the situation of advanced training in the discipline of rheumatology in Germany].Zeitschrift fur Rheumatologie · 2023Review
- [With RheMIT rheumatology centers can participate in the German national database-Expansion of the long-term rheumatological documentation].Zeitschrift fur Rheumatologie · 2023Article
- Time interval between the onset of connective tissue disease symptoms and first contact with a rheumatologist: results from the German National Database of collaborative arthritis centers.Rheumatology international · 2023Review
- [Celebrating 33 years of the DRFZ: Epidemiology and Health Services Research].Zeitschrift fur Rheumatologie · 2022Review
- Comparative Efficacy Randomized Controlled Trials in Rheumatology Guidelines.ACR open rheumatology · 2022Article
- Article
- [Treatment of rheumatoid arthritis and spondylarthritis with biologics].Der Internist · 2022Review
- Prescription of analgesics in patients with rheumatic diseases in Germany : A claims data analysis.Zeitschrift fur Rheumatologie · 2021Article
- Comorbidity and healthcare utilisation in persons with incident systemic lupus erythematosus followed for 3 years after diagnosis: analysis of a claims data cohort.Lupus science & medicine · 2021Article
- [Prescription of analgesics in patients with rheumatic diseases in Germany : A claims data analysis. German version].Zeitschrift fur Rheumatologie · 2021Article
- Acute anejaculation, hypogonadism, and fertility preservation in the setting of neurosarcoidosis: case report and literature review.F&S reports · 2020Article
- [Translational healthcare research : Show what is-Angela Zink, the grande dame of public health research in rheumatology].Zeitschrift fur Rheumatologie · 2020Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundSince 1993, data on the care and quality of life of patients with inflammatory rheumatic diseases have been collected in the German National Database (NDB) of the regional collaborative rheumatology centers.
objectiveIn this review long-term trends on treatment, disease activity and gainful employment of the most common inflammatory rheumatic diseases are presented and the most important analyses from 25 years of the NDB are summarized.
methodsBetween 15 and 17 rheumatological institutions take part in the NDB and once a year collect data from a total of more than 10,000 patients. The rheumatologists document the disease status and care, the patients report on their state of health and the effects of the disease.
resultsThe biologics era at the beginning of the twenty-first century has led to changes in the therapeutic spectrum of most inflammatory rheumatic diseases, especially in rheumatoid arthritis and ankylosing spondylitis. Some basic therapies formerly used are hardly used anymore and glucocorticoids are used less frequently. Methotrexate has remained the standard therapy for rheumatoid arthritis over the years. Nowadays, nearly 30% of patients with rheumatoid arthritis receive treatment with biologics. Disease activity, functional and social restrictions have decreased across all diseases.
conclusionThe improved health status of many patients with rheumatic diseases confirms the high level of care provided by the rheumatism centers involved in the NDB. The increasing specification of measuring instruments and the standardization of documentation systems are major challenges that the NDB will have to face in the coming years if it is to remain in the digital age.
Indexed as
Identifiers
31407089What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.